|
2024
|
Invention
|
Il-2 fusion proteins. Provided herein are novel IL-2 fusion proteins that include an IL-2 moiety ... |
|
|
Invention
|
Use of immunomodulation methods in combination with cytokine fusions for disease treatment. Provi... |
|
2023
|
Invention
|
Il-2 superantagonists constructs, methods and uses thereof. Human interleukin-2 (IL-2) muteins or... |
|
|
Invention
|
Dosing methods for use with il-2 superagonists, agonists, and fusions thereof. Human interleukin-... |
|
|
Invention
|
Interleukin-2 fusion proteins and uses thereof.
The present invention relates to interleukin-2 f... |
|
|
Invention
|
Uses and methods for il-2, il-13, and il-4 cytokine bifunctional molecules. Human interleukin-2 (... |
|
2022
|
Invention
|
Il-2 superagonists in combination with anti-pd-1 antibodies.
Human interleukin-2 (IL-2) muteins ... |
|
|
Invention
|
Interleukin-4 receptor-binding fusion proteins and uses thereof.
The present invention relates t... |
|
2021
|
Invention
|
Combination therapy of mdna55 and a vascular endothelial growth factor a (vegf-a).
Methods for t... |
|
|
Invention
|
Combination therapy of mdna55 and a vascular endothelial growth factor a (vegf-a). Methods for tr... |
|
|
Invention
|
Bifunctional superkines and uses thereof.
Bispecific human interleukin-2 (IL-2) cytokine fusions... |
|
|
Invention
|
Bifunctional superkines and uses thereof. Bispecific human interleukin-2 (IL-2) cytokine fusions ... |
|
2020
|
Invention
|
Interleukin-2 fusion proteins and uses thereof. The present invention relates to interleukin-2 fu... |
|
|
Invention
|
Il-4r as a biomarker in cancer.
Methods for using the human interleukin-4 receptor (IL-4) as a b... |
|
|
Invention
|
Il-4r as a biomarker in cancer. Methods for using the human interleukin-4 receptor (IL-4) as a bi... |
|
2019
|
Invention
|
Uses and methods for oncolytic virus targeting of il-4/il-13 and fusions thereof.
The present in... |
|
|
Invention
|
Il-13/il-4 superkines: immune cell targeting constructs and methods of use thereof.
Methods and ... |
|
|
Invention
|
Uses and methods for oncolytic virus targeting of il-4/il-13 and fusions thereof. The present inv... |
|
|
Invention
|
Il-13/il-4 superkines: immune cell targeting constructs and methods of use thereof. Methods and c... |
|
2018
|
Invention
|
Il-4-fusion formulations for treatment of central nervous system (cns) tumors.
The present inven... |
|
|
Invention
|
Il-4-fusion formulations for treatment of central nervous system (cns) tumors. The present invent... |
|
|
Invention
|
Interleukin-4 receptor-binding fusion proteins and uses thereof. The present invention relates to... |
|
|
Invention
|
Il-2 superagonists in combination with anti-pd-1 antibodies. Human interleukin-2 (IL-2) muteins o... |
|
|
Invention
|
Uses and methods for il-2 superagonists, agonists, and fusions thereof. Human interleukin-2 (IL-2... |
|
2017
|
Invention
|
Il-13 superkine: immune cell targeting constructs and methods of use thereof.
Methods and compos... |
|
|
Invention
|
Il-13 superkine: immune cell targeting constructs and methods of use thereof. Methods and composi... |
|
2016
|
Invention
|
Treating cancer stem cells using targeted cargo proteins.
The disclosure provides targeted cargo... |
